Jim Simons
TMCI icon

Jim Simons’s Treace Medical Concepts TMCI Stock Holding History

Jim Simons’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$701K Buy
+522,900
New +$1.04M ﹤0.01% 2442
2025
Q2 		– Sell
-126,800
Closed -$1.06M – 3901
2025
Q1 		$1.06M Buy
126,800
+14,800
+13% +$133K ﹤0.01% 2385
2024
Q4 		$833K Buy
112,000
+76,700
+217% +$513K ﹤0.01% 2595
2024
Q3 		$205K Sell
35,300
-171,200
-83% -$1.1M ﹤0.01% 3120
2024
Q2 		$1.37M Buy
206,500
+29,100
+16% +$235K ﹤0.01% 2125
2024
Q1 		$2.31M Buy
177,400
+139,098
+363% +$1.85M ﹤0.01% 1935
2023
Q4 		$488K Sell
38,302
-195,698
-84% -$1.98M ﹤0.01% 2794
2023
Q3 		$3.07M Buy
+234,000
New +$4.28M 0.01% 1599
2023
Q2 		– Sell
-75,600
Closed -$1.9M – 4261
2023
Q1 		$1.9M Buy
75,600
+37,900
+101% +$890K ﹤0.01% 2058
2022
Q4 		$867K Sell
37,700
-30,900
-45% -$711K ﹤0.01% 2613
2022
Q3 		$1.51M Buy
+68,600
New +$1.33M ﹤0.01% 2229

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jim Simons's TMCI Position: Q1 2026 in Review

Jim Simons opened a new position in Treace Medical Concepts (TMCI) in Q1 2026: 522,900 shares worth $701K. The stake represents ﹤0.01% of the portfolio and ranks #2442 among its holdings. This is a return to the name: Jim Simons previously reported a position in TMCI as recently as Q1 2025.

Jim Simons first reported a position in TMCI in Q3 2022 and has held it in 11 quarters since. The position peaked at $3.07M in Q3 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Jim Simons held 522,900 shares of Treace Medical Concepts worth $701K as of Q1 2026.
  • Treace Medical Concepts was a new Jim Simons position in Q1 2026.
  • Treace Medical Concepts made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2442 holding.
  • Jim Simons first reported a position in Treace Medical Concepts in Q3 2022 and has held it in 11 quarters since.
  • Jim Simons's Treace Medical Concepts position peaked at $3.07M in Q3 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.